Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

New generation must take South Africa into the Promised Land
2012-07-23

 

Prof. Somadoda Fikeni talks about Reconciliation and Social Justice on Nelson Mandela Day.
Photo: Johan Roux
18 July 2012

 

Former President Nelson Mandela was part of the Moses generation that took people out of bondage. What the country now needs is the Joshua generation that will take it into the promise land.

This is according to political analyst and public commentator, Prof. Somadoda Fikeni. He was speaking to staff and students participating in the Global Leadership Summit, which took place on the Bloemfontein Campus from 8-20 July 2012. Prof. Fikeni took part in a panel discussion on Justice and Reconciliation. He and other panellists observed that there were still many challenges facing reconciliation in South Africa.

Referring to controversial statements made by Helen Zille, Julius Malema and Pieter Mulder, Prof. Fikeni said public discourse had become toxic and that the country was faced by a leadership crisis.

Ms Yasmin Sooka, a former Commissioner of the Truth and Reconciliation Commission (TRC) and Executive Director of the Foundation for Human Rights South Africa, asked if reconciliation had not come at the expense of redress. She said that to date there had been no restitution.

Ms Lihlumelo Toyana, a post-graduate student at the university, was also part of the panel. She told the audience that 18 years into democracy, there are still people waiting for justice. Toyana said young people hoped to see change and wondered if South Africans would ever sit down and have dialogue about the past. “We need closure; we need to take the country forward.”

The other panelists were lawyer, politician and former Human Rights Commissioner Prof. Leon Wessels; a professor from the University of Cape Town’s Law Faculty, Prof. Jaco Barnard-Naude; and psychologist, Prof. Alain Tschudin.
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept